<DOC>
	<DOCNO>NCT02425917</DOCNO>
	<brief_summary>This study design compare effect IPC post-operative circulation lower limbs gekoTM device total hip replacement procedure .</brief_summary>
	<brief_title>IPC-CALF Versus GEKO Post-op Total Hip Patients</brief_title>
	<detailed_description />
	<criteria>1 . Male Female 2 . Aged 1880 year 3 . Be good general health fitness clinical requirement plan hip replacement . 4 . Free significant abnormal finding determine medical history ( specifically absence DVT haematological disorder . 5 . No history sign drug abuse ( include alcohol ) , licit illicit . 6 . Has use medication ( prescribed overthecounter include herbal remedy ) judge significant Principal Investigator ( PI ) thirty ( 30 ) day precede study . 7 . Able understand Patient Information Sheet willing sign write Informed Consent Form . 8 . Able willing follow protocol requirement . 1 . Are require hip revision surgery 2 . History sign significant haematological disorder ( especially relation clot coagulation previous deep superficial vein thrombosis/pulmonary embolism ) . 3 . Significant Peripheral arterial disease ( ABPI &lt; 0.8 ) , varicose vein low limb ulceration ischemia . 4 . Recent surgery within last 3 month ( abdominal , gynaecological , hip knee replacement ) . 5 . Recent trauma lower limb . 6 . Chronic Obesity ( BMI Index &gt; 40kg/m2 ) . 7 . Pregnancy . 8 . Significant history follow disease i. Cardiovascular : Recent MI ( &lt; 6 month ) ii . Percutaneous Coronary Intervention ( PCI ) stent ( &lt; 3 month Bare metal stent ( BMS ) &lt; 12 month Drug Eluding Stent ( DES ) iii . Moderate severe CCF , uncontrolled AF iv . Neurological : Stroke , Hemiplegia/Paraplegia , Myopathies v. Renal : Moderate severely impair renal function vi . Hepatic : Moderate severely impair hepatic function vii . Psychiatric disorder viii . Dermatological condition affect low limb ix . Haematological condition i.e . coagulation disorder , sickle cell disease 9 . A pulse rate le 40 beats/minute 10 . A sit systolic blood pressure &gt; 180 &lt; 100 mmHg and/or sit diastolic pressure &gt; 100 mmHg . 11 . Any significant illness four ( 4 ) week precede hip replacement surgery . 12 . Participation clinical study eight ( 8 ) week precede screening period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>